.With a tough track record for determining rough diamonds, Bain Financing Daily Life Sciences (BCLS)...
.The latest selection to merge Genentech's two cancer cells divisions was made for "medical causes,"...
.Terns Pharmaceuticals' choice to fall its own liver disease ambitions may however pay, after the bi...
.Merck & Co.'s long-running initiative to land a punch on little cell bronchi cancer cells (SCLC)...
.Some patients with non-small cell lung cancer (NSCLC) possess anomalies in a genetics referred to a...
.MBX has fleshed out strategies to take in over $136 thousand from its own IPO as the biotech looks ...
.Relay Therapies has actually beaten its survival objective in a first-in-human breast cancer study,...
.AstraZeneca has actually used expert system to create an unique biomarker for its Daiichi Sankyo-pa...
.AstraZeneca managers mention they are "not concerned" that the breakdown of tozorakimab in a phase ...
.Welcome to this week's Chutes & Ladders, our summary of significant management hirings, shooting...